This page is not available in the language that has been selected and will appear in English.
This page is not available in the language that has been selected.
Halaman ini tidak tersedia dalam bahasa yang dipilih.
Trang này không có sẵn bằng ngôn ngữ đã chọn.
此页面不提供所选语言的版本。
1234 5678
John hits the road to celebrate the end of cancer treatment.
John hits the road to celebrate the end of cancer treatment
Sed aliquam tellus sit amet lectus suscipit molestie. Curabitur nec ultrices nunc, id feugiat nisi. Nam iaculis malesuada ex eget dictum.
Find a clinical trial that suits you and your cancer diagnosis
ARC-20
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Locations Adelaide, Gosford
Diagnosis Advanced solid tumours
POPSTAR II
Lu-PSMA for Oligometastatic Prostate Cancer Treated With Stereotactic Ablative Radiotherapy
Locations Epworth Richmond, Epworth Freemasons, Moreland, Holmesglen, Mulgrave
Diagnosis Prostate cancer
rechARge / CA071-1000
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Locations Hobart, Adelaide
78278343PCR1003
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer
Locations Adelaide
ARTEMIDE-Lung02 / D702BC00001
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Locations Townsville, Southport
Diagnosis Lung cancer
ARTEMIDE-Lung03 / D702FC00001
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
Previous